This inventor holds 1 USPTO granted patent. Top assignee: F. Hoffmann-La Roche Ag. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Gabor Gyulveszi - Innovator in Cancer Treatment
Introduction
Gabor Gyulveszi is an inventor based in Schlieren, Switzerland. He is focused on developing innovative therapies for cancer treatment. His work primarily revolves around the combination of PD-1 axis binding antagonists and LRRK2 inhibitors.
Latest Patent Applications
Gabor Gyulveszi has submitted a patent application titled "COMBINATION THERAPY OF PD-1 AXIS BINDING ANTAGONISTS AND LRRK2 INHIBITORS." This application relates to combination therapies that utilize PD-1 axis binding antagonists and LRRK2 inhibitors for the treatment of cancer. The invention aims to enhance the effectiveness of cancer therapies through this innovative combination.
Conclusion
Gabor Gyulveszi is making significant strides in the field of cancer treatment through his innovative approaches. His latest patent application reflects his commitment to advancing medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile